MARKETS

Stocks in Focus: Lupin, KPI Green Energy, IRB Infra, and Others

Stocks in Focus: RailTel Corp, Reliance Industries, and Others - EP
Picture Source: Internet

The GIFT Nifty futures, which are an early indicator of the Nifty50 index stocks, were trading higher by 66 points at 26,017, indicating that the domestic benchmark indices are likely to make a positive start on Monday. 

Earlier on Friday, 14 November, the Domestic benchmark indices S&P BSE Sensex surged by 84 points or 0.10%, and settled at 84,561, while the Nifty50 traded 0.12% higher or 30 points, closing at 25,910.

Here are some stocks that are likely to remain in focus on 17 November.

Lupin: The USFDA completed a product-specific Pre-Approval Inspection at Lupin’s Unit-1 oral solid dosage facility in Nagpur. The inspection, conducted from 10 November to 14, concluded with zero 483 observations.

KPI Green Energy: KPI Green Energy won a Rs 696 crore contract from SJVN for a 200 MW solar project in Khavda, Gujarat. The project includes supply, construction, commissioning, and three years of operations and maintenance.

IRB Infrastructure Developers: IRB Infrastructure Trust, the Private InvIT sponsored by IRB Infrastructure Developers, received the Letter of Award (LoA) from the National Highways Authority of India (NHAI) for the TOT-17 Bundle. The project covers 366 km of the Lucknow–Ayodhya–Gorakhpur Corridor on NH-27 and part of the Lucknow–Varanasi Corridor on NH-731 in Uttar Pradesh. For the 20-year revenue-linked concession period, the Trust will pay NHAI an upfront concession fee of Rs 9,270 crore.

TruAlt Bioenergy: TruAlt Bioenergy signed an MoU with the Andhra Pradesh Economic Development Board (APEDB) to develop one of the world’s largest Sustainable Aviation Fuel (SAF) production facilities in Andhra Pradesh. Under this agreement, the company will invest around Rs 2,250 crore to set up an integrated ethanol-to-SAF manufacturing plant.

Alembic Pharma: Alembic Pharmaceuticals secured final approval from the USFDA for its Abbreviated New Drug Application (ANDA) for Diltiazem Hydrochloride tablets, which are used to treat chronic stable angina.

The future of investing is here!
Unicorn Signals leverages advanced AI technology to provide you with powerful market predictions and actionable stock scans. Download the app todayand 10x your trading & investing journey!

Click here to check market prediction for next trading session.

Get Daily Prediction & Stocks Tips On Your Mobile


I would like to receive communication from EquityPandit via sms, email, whatsapp, Google RCS for offers, updates etc.



πŸ“°
News
πŸ“ˆ
Prediction
πŸ“Š
FII / DII
πŸ‘”
Advisory
Get 1-2 Index Option Trades Daily